share_log

Inotiv, Inc. to Participate in Upcoming Jefferies and Craig-Hallum Investor Conferences

Inotiv, Inc. to Participate in Upcoming Jefferies and Craig-Hallum Investor Conferences

Inotiv, Inc.將參加即將舉行的傑富瑞和克雷格-哈勒姆投資者會議
GlobeNewswire ·  11/07 21:00

WEST LAFAYETTE, Ind., Nov. 07, 2024 (GLOBE NEWSWIRE) -- Inotiv, Inc. (Nasdaq: NOTV) (the "Company" or "Inotiv"), a leading contract research organization specializing in nonclinical and analytical drug discovery and development services and research models and related products and services, today announced that Robert Leasure Jr., President and Chief Executive Officer, will present at the upcoming Jefferies London Global Healthcare Conference. Beth Taylor, Chief Financial Officer, will participate at the upcoming 15th Annual Craig-Hallum Alpha Select Conference.

WESt LAFAYETTE, 2024年11月07日,印第安納州(GLOBE NEWSWIRE)--Inotiv,Inc.(納斯達克:NOTV)(「公司」或「Inotiv」),是一家領先的專門從事非臨床和分析藥物研發服務、研究模型以及相關產品和服務的合同研究組織,在今日宣佈,首席執行官Robert Leasure Jr.將在即將舉行的Jefferies倫敦全球醫療保健大會上發表演講。首席財務官Beth Taylor將參加即將舉行的第15屆年度Craig-Hallum Alpha Select Conference。

Conference Details

會議詳情

Jefferies 2024 London Global Healthcare Conference
Presenter: Robert Leasure Jr., President and Chief Executive Officer
Location: Waldorf-Hilton Hotel, London
Presentation time: Tuesday, November 19th, at 1:30 p.m. GMT (8:30 a.m. ET).
To learn more about the Jefferies event: LINK

2024年Jefferies倫敦全球醫療保健大會
主講人:Robert Leasure Jr.,總裁兼首席執行官
地點:倫敦華爾道夫希爾頓酒店
演講時間:11月19日星期二,GMT下午1:30(美國東部時間上午8:30)
要了解有關傑富利活動的更多信息:鏈接

The live webcast can be accessed in the "Investors" section of Inotiv's website and will be archived for approximately 90 days following the event.

現場網絡直播可在Inotiv網站的"投資者"部分訪問,並將在活動結束後約90天存檔。

15th Annual Craig-Hallum Alpha Select Conference
Date: Tuesday, November 19th
Location: Sheraton NY Times Square Hotel, New York, NY

第15屆Craig-Hallum Alpha Select會議
日期:週二,11月19日
地點:紐約市時代廣場希爾頓酒店,紐約

Beth Taylor is scheduled to host one-on-one meetings with investors and attendees during the conference. Investors interested in arranging one-on-one meetings should contact their Craig-Hallum conference representative.

Beth Taylor計劃在會議期間與投資者和與會者舉行一對一會議。有興趣安排一對一會議的投資者應聯繫他們的Craig-Hallum會議代表。

To learn more about the Craig-Hallum event: LINK

要了解更多關於Craig-Hallum活動的信息:LINK

About the Company

關於公司

Inotiv, Inc. is a leading contract research organization dedicated to providing nonclinical and analytical drug discovery and development services and research models and related products and services. The Company's products and services focus on bringing new drugs and medical devices through the discovery and preclinical phases of development, all while increasing efficiency, improving data, and reducing the cost of taking new drugs to market. Inotiv is committed to supporting discovery and development objectives as well as helping researchers realize the full potential of their critical R&D projects, all while working together to build a healthier and safer world. Further information about Inotiv can be found here: .

Inotiv, Inc.是一家領先的合同研究組織,致力於提供非臨床和分析藥物發現和開發服務、研究模型以及相關產品和服務。公司的產品和服務專注於將新藥物和醫療設備通過發現和臨床前階段的開發,同時提高效率,改善數據,降低推向市場的新藥物成本。Inotiv致力於支持發現和開發目標,幫助研究人員實現其關鍵研發項目的全部潛力,共同努力構建一個更健康、更安全的世界。有關Inotiv的更多信息可以在這裏找到: .

This release may contain forward-looking statements that are subject to risks and uncertainties including, but not limited to, risks and uncertainties related to the impact of recent events related to non-human primate matters on the Company's business, operations, results, financial condition, cash flows, and assets, the Company's ability to service its outstanding indebtedness and comply with covenants under its credit agreement, compliance with the Resolution and Plea Agreements with the DOJ and the expected impacts on the Company related to the compliance plan, compliance monitor, and the expected financial commitments, changes in the market and demand for the Company's products and services, the development, marketing and sales of products and services, changes in technology, industry and regulatory standards, the timing of acquisitions and the successful closing, integration and business and financial impact thereof, governmental regulations, inspections and investigations, claims and litigation against or involving the Company, its business and/or its industry, the impact of site closures and consolidations, expansion and related efforts, and various other market and operating risks, including those detailed in the Company's filings with the U.S. Securities and Exchange Commission.

本公告可能包含前瞻性聲明,受各種風險和不確定因素的影響,包括但不限於與公司業務、運營、成果、財務狀況、現金流和資產有關的近期非人類靈長類動物事件的影響,公司履行其未償還債務並遵守其信貸協議條款的能力,與美國司法部達成的決議和認罪協議的合規情況以及預期對公司造成的合規計劃、合規監察員和預期的財務承諾的影響,市場對公司產品和服務的需求變化,產品和服務的開發、營銷和銷售,技術、行業和監管標準的變化,收購的時間和成功完成、整合和業務和財務影響,政府監管、檢查和調查,針對公司以及涉及公司、其業務和/或行業的索賠和訴訟,場地關閉和整合、擴張等努力的影響,以及市場和運營風險,包括公司在美國證券交易委員會的備案中詳細披露的那些風險。

Company Contact Investor Relations
Inotiv, Inc. LifeSci Advisors
Beth A. Taylor, Chief Financial Officer Bob Yedid
(765) 497-8381 (516) 428-8577
beth.taylor@inotiv.com bob@lifesciadvisors.com
公司聯繫 Marcia Novero Innodata Inc. Mnovero@innodata.com (201) 371-8015 投資者關係
Inotiv公司 LifeSci Advisors
財務長貝絲·A·泰勒 Bob Yedid
(765) 497-8381 (516) 428-8577
beth.taylor@inotiv.com bob@lifesciadvisors.com

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論